Scheme 1. Deoxyconduramines as Key Building Blocks
Scheme 2. Retrosynthetic Analysis of Aminocyclitols 2
addition of vinylmetal reagents. Moreover, all of the stereo-
isomers of aldehyde 4 had already been synthesized in our
research group13 from chiral unsaturated epoxide 5 or its
enantiomer.
Moreover, these compounds have proven most useful as
synthetic precursors of amino- and diaminocyclitols, having
been used as intermediates for azasugars, aminosugars,
sphingosines, and narcissus alkaloids. Oseltamivir phosphate
(Tamiflu), an orally administered drug for the treatment and
prevention of influenza infections, is an important example
of a clinically useful aminocyclitol.10 Much effort has been
devoted to the development of synthetic routes to these
compounds and their derivatives,9-11 which are normally
accessed via functional group manipulation of carbohydrates
or other natural products.
Building blocks for carbasugar synthesis can be obtained
through manipulation of the double bond of the synthetic
4-deoxy-3-conduramines (1). A few strategies have been
developed to convert this class of compound or synthetic
equivalents into conduramines11a and deoxystreptamines.12
With this in mind, we sought to develop a stereodivergent
and practical asymmetric synthesis of 4-deoxy-3-con-
duramines 1 (Scheme 1). We envisaged that dihydroxylation
of deoxyconduramines 1 would be a convenient entry to
deoxyinosamines 2, a new family of aminocyclitols.
As shown in Scheme 2, in our approach, all of the
stereoisomers of deoxyconduramines 1 would be obtained
from the ring-closing metathesis (RCM) of dienes 3 which,
in turn, would be obtained from the known aldehydes 4 by
Our synthesis started from epoxy alcohol 5, prepared
according to a literature procedure14 in 93% ee by Sharpless
epoxidation15 of 2,5-hexadien-1-ol, which is readily available
in multigram quantities from propargyl alcohol and allyl
bromide. The product was then subjected to a high-yielding
procedure (epoxide ring opening, azide reduction, and
protection) developed in our laboratory to yield amino
alcohol 6a13 with the anti configuration. Protection as the
acetal followed by deprotection afforded the cis isomer of
alcohol 8 (Scheme 3). Oxidation of the alcohol gave the cis
isomer of aldehyde 4, which could be epimerized16 in the
presence of catalytic base to afford an 84:16 trans/cis mixture
of 4. However, to avoid using a mixture of products in the
following steps, the trans isomer of 8 was prepared by a
completely stereoselective alternative procedure based on
inversion of the secondary alcohol. Compound 6a was
subjected to Mitsunobu conditions17 (p-nitrobenzoic acid and
DIAD in toluene, as THF led to lower yields) to give the
p-nitrobenzoate ester with the syn configuration, which was
reduced with RedAl (attempts to use Dibal-H resulted in a
decreased yield) to yield 6b. Alcohol 6b was then submitted
to the same reaction sequence as 6a to afford the diastereo-
merically pure trans isomer of 8 (Scheme 3).
With both isomers of alcohol 8 in hand, we proceeded to
study the diastereoselective addition of vinylmetal reagents
(5) Ogawa, S.; Asada, M.; Ooki, Y.; Mori, M.; Itoh, M.; Korenaga, T.
Bioorg. Med. Chem. 2005, 13, 4306.
(6) (a) Horii, S.; Iwasa, T.; Mizuta, E.; Kameda, Y. J. Antibiot. 1971,
24, 59. (b) Mahmud, T. Nat. Prod. Rep. 2003, 20, 127.
(12) (a) To´th, Z. G.; Pelyva´s, I. F.; Szegedi, C.; Benke, P.; Magyar, E.;
Miklovicz, T.; Batta, G.; Sztaricskai, F. Carbohydr. Res. 1997, 300, 183.
(b) Pelyva´s, I. F.; To´th, Z. G.; Vereb, G.; Balla, A.; Kovacs, E.; Gorzsas,
A.; Sztaricskai, F.; Gergely, P. J. Med. Chem. 2001, 44, 627. (c) Busscher,
G. F.; Rutjes, F. P. J. T.; van Delft, F. L. Tetrahedron Lett. 2004, 45, 3629.
(d) Busscher, G. F.; Groothuys, S.; De Gelder, R.; Rutjes, F. P. J. T.; van
Delft, F. L. J. Org. Chem. 2004, 69, 4477. (e) Verhelst, S. H. L.; Wennekes,
T.; van der Marel, G. A.; Overkleeft, H. S.; van Boeckel, C. A. A.; van
Boom, J. H. Tetrahedron 2004, 60, 2813.
(13) Ginesta, X.; Pasto´, M.; Perica`s, M. A.; Riera, A. Org. Lett. 2003,
5, 3001.
(14) Alco´n, M.; Moyano, A.; Perica`s, M. A.; Riera, A. Tetrahedron:
Asymmetry 1999, 10, 4639.
(15) Gao, Y.; Hanson, R. M.; Klunder, J. M.; Ko, S. Y.; Masamune, H.;
Sharpless, K. B. J. Am. Chem. Soc. 1987, 109, 5765.
(16) Pasto´, M.; Moyano, A.; Perica`s, M. A.; Riera, A. Tetrahedron Lett.
1998, 39, 1233.
(17) (a) Mitsunobu, O. Synthesis 1981, 1. (b) Hughes, D. L. Org. React.
1992, 42, 335.
(7) (a) Horii, S.; Kameda, Y. J. Chem. Soc., Chem. Commun. 1972, 747.
(b) Kameda, Y.; Asano, N.; Yoshikawa, M.; Takeuchi, M.; Yamaguchi,
T.; Matsui, K.; Horii, S.; Fukase, H. J. Antibiot. 1984, 37, 1301
(8) (a) Posternack, T. The Cyclitols; Holden-Day, Inc.: San Francisco,
1965; pp 211-212. (b) Balci, M.; Su¨tbeyaz, Y.; Sec¸en, H. Tetrahedron
1990, 46, 3715. (c) Lysek, R.; Vogel, P. Tetrahedron 2006, 62, 1.
(9) Lysek, R.; Schu¨tz, C.; Vogel, P. Bioorg. Med. Chem. Lett. 2005, 15,
3071.
(10) Harrington, P. J.; Brown, J. D.; Foderaro, T.; Hughes, R. C. Org.
Process Res. DeV. 2004, 8, 86 and references therein.
(11) (a) Toung, R. L.; Liu, Y.; Muchowski, J. M.; Wu, Y. J. Org. Chem.
1998, 63, 3235 and references therein. (b) McDonough, M. J.; Stick, R.
V.; Tilbrook, M. G. Aust. J. Chem. 1999, 52, 143. (c) Akgu¨n, H.; Hudlicky,
T.; Tetrahedron Lett. 1999, 40, 3081. (d) Spielvogel, D.; Kammerer, J.;
Keller, M.; Prinzbach, H. Tetrahedron Lett. 2000, 41, 7863. (e) Trost, B.
M.; Dudash, J.; Hembre, E. J. Chem.-Eur. J. 2001, 7, 1619. (f) Serrano,
P.; Llebaria, A.; Delgado, A. J. Org. Chem. 2005, 70, 7829.
3070
Org. Lett., Vol. 8, No. 14, 2006